---
figid: PMC8897942__12935_2022_2523_Fig1_HTML
figtitle: MUC1 is a potential target to overcome trastuzumab resistance in breast
  cancer therapy
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Patella vulgata
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC8897942
filename: 12935_2022_2523_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8897942/figure/Fig1/
number: F1
caption: MUC1 interacts with several oncogenic pathways like NF-κB. It can activate
  TGFβ-activated Kinase (TAK) directly and activated NFκB pathway promotes survival
  and metastasis in BC cells. Besides, MUC1-CD is necessary for TWIST activation and
  it correlates to overexpression of cyclin D in BC cells. Moreover, MUC1-CD inhibits
  P53 activity in BC cells, thus it blocks apoptosis in these cells. MUC1-CD has wide
  range of interactions with different oncogenic and apoptotic molecules. In general,
  it promotes cell proliferation and resistance to apoptosis in BC cells
papertitle: MUC1 is a potential target to overcome trastuzumab resistance in breast
  cancer therapy.
reftext: Aysooda Hosseinzadeh, et al. Cancer Cell Int. 2022;22:110.
year: '2022'
doi: 10.1186/s12935-022-02523-z
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central
keywords: MUC1 | Trastuzumab | HER2 | Cancer | Drug Resistance
automl_pathway: 0.9479358
figid_alias: PMC8897942__F1
figtype: Figure
redirect_from: /figures/PMC8897942__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8897942__12935_2022_2523_Fig1_HTML.html
  '@type': Dataset
  description: MUC1 interacts with several oncogenic pathways like NF-κB. It can activate
    TGFβ-activated Kinase (TAK) directly and activated NFκB pathway promotes survival
    and metastasis in BC cells. Besides, MUC1-CD is necessary for TWIST activation
    and it correlates to overexpression of cyclin D in BC cells. Moreover, MUC1-CD
    inhibits P53 activity in BC cells, thus it blocks apoptosis in these cells. MUC1-CD
    has wide range of interactions with different oncogenic and apoptotic molecules.
    In general, it promotes cell proliferation and resistance to apoptosis in BC cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK9
  - IKBKE
  - IKBKG
  - MUC1
  - TWIST1
  - CCND1
  - CCND2
  - CCND3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - HIF1A
  - EPAS1
  - HIF3A
  - TP53
  - TP63
  - TP73
  - STAT3
  - CTNNB1
  - Muc1
  - Twist1
  - Pik3cg
  - Akt1
  - Mtor
  - Tp53
  - Stat3
  - Ctnnb1
  - Errfi1
  - Ikbke
  - Pik3r1
  - Trp53
  - tak
  - Tak1
  - Takl2
  - key
  - twi
  - CycD
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Tor
  - sima
  - p53
  - betaTub60D
  - hth
  - arm
---
